Date of management change: May 10, 2023
Seattle, WA-based Impel-Pharmaceuticals Appointed Michael Kalb as Chief Financial Officer
Impel Pharmaceuticals specializes in Precision Olfactory Delivery (POD) nasal devices for Alzheimers, migraine, and other central nervous system diseases.
Michael Kalb is CFO at Catalyst Pharmaceuticals. Previously, Michael held various senior HR leadership roles in the industry.
News
Short ProfileName: Michael Kalb
Title: Chief Financial Officer
Company: Impel Pharmaceuticals
Industry: Pharmaceuticals
Current Contact InfoEmail: *****@catalystpharma.com
Phone:.***.***.*20*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: Grywinski Lisa, Neczypor Christopher, Simon Randy, Torres Bridget, Chu Ellis, Sultan Salma, Turner Corren, Garon Christian, Horn Elad, Linde Yvette, Tolliver Marian
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
